News
Hosted on MSN29d
Scholar Rock SMA drug shows muscle function benefitGlobalData anticipates that this growth will be driven in part by the approval of three SMA therapies, including Scholar Rock’s apitegromab. Other impactful therapies are set to be Roche’s RG- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback